Shawnice Williams

Shawnice Williams serves as a primary contracting professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical research for infectious, immunologic, and allergic disease threats. She manages the acquisition of high-complexity research and development services, primarily focused on laboratory infrastructure, diagnostic tool development, and medical countermeasure innovation. Her work directly enables NIAID’s strategic priorities in biosafety, biocontainment, and rapid response capabilities, ensuring that critical scientific needs are met through timely, compliant, and technically sound procurement actions. Williams maintains a consistent procurement relationship with Quality Biological, Inc., a key vendor specializing in biological reference materials and pathogen-derived reagents essential for high-containment research. She also collaborates with GENOMIC LABS LTD and other specialized providers to secure advanced genomic and diagnostic technologies. Her contracting patterns reflect a preference for established, technically proficient contractors with proven expertise in life sciences R&D, emphasizing reliability, regulatory compliance, and scientific rigor over volume-based sourcing. Williams does not utilize socioeconomic set-asides, with 100% of her acquisitions conducted under full and open competition. This reflects a mission-driven focus on technical capability and urgency, prioritizing the most qualified vendors regardless of size or certification status. While small business participation is not formally targeted, her portfolio remains open to qualified small entities that meet stringent scientific and operational requirements. Her procurement activity is exclusively aligned with NAICS 541715—Research and Development in the Physical, Engineering, and Life Sciences. She procures specialized services including virology and immunology research, biosafety level 3/4 laboratory support, assay development, and bioanalytical testing, demonstrating deep expertise in the technical domains of infectious disease diagnostics and biomedical countermeasure innovation.